Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Dr. Prem Aggarwal

Dr Prem Aggarwal, (MD Medicine, DNB Cardiology) is a Cardiologist by profession and also the Co-founder and Chairman of Medical Dialogues. He focuses on news and perspectives about cardiology, and medicine related developments at Medical Dialogues. He can be reached out at drprem@medicaldialogues.in

Home

Dr. Prem Aggarwal

Articles By : Dr. Prem Aggarwal

High Sedentary Time After ACS Doubles Risk of Cardiac Events, but Cutting It May Lower Mortality: Study

Dr. Prem Aggarwal27 May 2025 11:00 AM IST

USA: A new prospective study published in Circulation: Cardiovascular Quality and Outcomes has raised concern over excessive sedentary behavior among...

Maintaining SBP Within 120-140 mmHg May Reduce Atherosclerosis Risk, Study Finds

Dr. Prem Aggarwal26 May 2025 9:00 AM IST

China: A recent study published in Scientific Reports suggests that maintaining systolic blood pressure (SBP) consistently within the recommended...

Simple test could better predict risk of heart disease, reveals research

Dr. Prem Aggarwal23 May 2025 8:45 PM IST

For almost 60 years, measuring cholesterol levels in the blood has been the best way to identify individuals at high risk of cardiovascular disease....

Invasive Versus Conservative Strategy in NSTEMI

Complete Revascularization Offers Long-Term Advantage in STEMI With Multivessel Disease, Study Finds

Dr. Prem Aggarwal23 May 2025 8:30 AM IST

Denmark: A decade after undergoing primary treatment, patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery...

Meta-analysis finds no Benefit in Routine Use of cerebral embolic protection During TAVI- EuroPCR 2025

Dr. Prem Aggarwal22 May 2025 12:00 PM IST

The EuroPCR Course Directors have chosen three major late-breaking trials to be unveiled at EuroPCR 2025. These were selected for their strong design,...

FFR-Guided PCI Shows Benefit in TAVI Patients with Intermediate CAD: The FAITAVI trial(EuroPCR 2025)

Dr. Prem Aggarwal22 May 2025 8:45 AM IST

EuroPCR Course Directors have selected three significant late-breaking trials for first-time presentation at EuroPCR 2025, chosen for their robust...

4C-ACS Trial Supports 1-Month DAPT De-Escalation in East Asian ACS Patients: EuroPCR 2025

Dr. Prem Aggarwal22 May 2025 7:30 AM IST

While dual antiplatelet therapy (DAPT) has been the standard for managing acute coronary syndrome (ACS) patients undergoing PCI, there is growing...

Olezarsen Significantly Reduces Triglycerides in Moderate hypertriglyceridemia Patients at ASCVD Risk: Essence study

Dr. Prem Aggarwal21 May 2025 9:00 AM IST

Topline results from the Essence study show that olezarsen significantly lowered mean triglyceride levels compared to placebo in individuals with...

Waist-to-height ratio may predict heart failure incidence, suggests research

Dr. Prem Aggarwal20 May 2025 7:30 AM IST

Waist-to-height ratio predicts heart failure incidence, according to research presented today at Heart Failure 2025, a scientific congress of the...

Resistant Hypertension: Amiloride Found Noninferior to Spironolactone, JAMA Study Finds

Dr. Prem Aggarwal19 May 2025 9:15 AM IST

South Korea: A recent randomized clinical trial published in JAMA has shown that amiloride, a potassium-sparing diuretic, is not inferior to...

Aficamten Shows Promise Over Metoprolol in Phase 3 MAPLE-HCM Trial for Obstructive HCM

Dr. Prem Aggarwal17 May 2025 9:00 AM IST

Topline results were released from the phase 3 MAPLE-HCM trial, which compared aficamten with metoprolol in 175 adults with symptomatic obstructive...

Adult-onset type 1 diabetes increases risk of CV disease and death, reveals research

Dr. Prem Aggarwal15 May 2025 8:45 AM IST

A new study in the European Heart Journal shows that people who develop type 1 diabetes in adulthood have an increased risk of cardiovascular disease...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok